Year 2012

Intellectual Property Strategy: A Wise Man’s Guide

A recently published book by Harvard Law School Professor John Palfrey offers a thoughtful and useful handbook for executives or just about anyone else to better understand and use intellectual property, in ways that encourage sharing and openness.

EU Copyright Levy Debate Rekindled; UK Needs Better Licensing, Study Finds

Stalled talks on Europe's broken system of private copying levies resumed on 2 April, with European Commission-appointed mediator António Vitorino laying out his goals and urging parties to move beyond their entrenched positions. Meanwhile, a report for rights owners found that abolishing levies will hurt them as well as device makers and, possibly, consumers. And in another copyright-related development, a UK government study identified problems with the country's copyright licensing regime.

Honduras Files WTO Dispute Case Vs. Australia Over Tobacco IPR

Honduras announced today it has requested formal consultations with Australia under the World Trade Organization dispute settlement procedures, charging that Australia's public health law requiring tobacco to be sold in plain packaging violates the WTO intellectual property agreement.

External Review Of WIPO Technical Assistance Stirs Debate

Members of the World Intellectual Property Organization are quietly but heatedly discussing how to address an external review of WIPO technical assistance in the lead-up to the next Committee on Development and IP (CDIP) meeting, according to sources. And some are watchful that there not be an effort to bury the substantive and at-times critical review, even as WIPO has issued a lengthy response to it.

Book Details IP Rights And Development

Using on-the-ground research in Africa and the Netherlands, the authors of a recent book looked at the impact of intellectual property on agriculture and health in developing countries. The study made some surprise findings in relation to IP and development, such as IP-related obstacles to knowledge and technology transfer.

WHO / EU “Bad Medicine” Plans: Flaws, Coordination Gaps

The latest World Health Organization / European Union plans to counter the trade in counterfeit and substandard medicines aim to ensure that medicines in the developing world are safe. As such, though both plans appropriately address quality issues, they fall short of adequate coordination and collaboration with each other, and also present substantial flaws, Daniele Dionisio writes.